Table 1.
Demographic data of Control Cohort (patients without ETIC) and Study Cohort (patients with ETIC)
| Control Cohort |
Study Cohort |
p value | |
|---|---|---|---|
| n=53 | n=38 | ||
| Age | 38±16 | 38±20 | 0.989 |
| Male (%) | 81% | 79% | 0.796 |
| Blunt (%) | 89% | 77% | 0.154 |
| ISS | 9±7 | 14±13 | 0.014 |
| Positive head CT (%) | 35.7% | 45.8% | 0.444 |
| Head AIS | 1±2 | 1±2 | 0.980 |
| EMS Data | |||
| Crystalloid (ml) | 452±552 | 852±1166 | 0.040 |
| Systolic BP (mmHg) | 135±24 | 128±28 | 0.329 |
| Diastolic BP (mmHg) | 80±20 | 65±24 | 0.009 |
| Respiratory rate | 18±8 | 19±5 | 0.672 |
| Heart Rate (bpm) | 96±26 | 104±29 | 0.226 |
| GCS | 13±4 | 13±4 | 0.696 |
| ECC Data | |||
| Crystalloid (ml) | 96±183 | 350±1042 | 0.091 |
| Systolic BP (mmHg) | 136±26 | 134±35 | 0.771 |
| Diastolic BP (mmHg) | 78±18 | 77±20 | 0.898 |
| Respiratory rate | 17±8 | 19±8 | 0.281 |
| Heart Rate (bpm) | 97±21 | 97±26 | 0.482 |
| GCS | 14±3 | 13±4 | 0.331 |
| Laboratory Data | |||
| Platelet count (103/μl) | 273±60 | 212±88 | <0.001 |
| PT (sec) | 12.0±0.7 | 15.1±1.9 | <0.001 |
| PTT (sec) | 26.9±3.7 | 32.2±25.3 | 0.138 |
| Fibrinogen (mg/dl) | 312±110 | 250±95 | 0.027 |
| Hematocrit (%) | 41.5±4.2 | 36.1±7.1 | <0.001 |
| Base excess | −3.9±3.2 | −3.4±5.4 | 0.740 |
| Outcome Data | |||
| Hospital LOS (days) | 9±13 | 15±24 | 0.120 |
| 28 d Mortality | 3.7% | 8.1% | 0.646 |
| 24 Hour Blood Utilization Data | |||
| RBC units transfused | 0±0 | 2±4 | 0.002 |
| RBC patients transfused (%) | 1.8% | 32.4% | <0.001 |
| Plasma units transfused | 0±0 | 1±3 | 0.002 |
| Plasma patients transfused (%) | 0.0% | 29.7% | <0.001 |
| Platelet units transfused | 0±0 | 2±4 | 0.010 |
| Platelets patients transfused (%) | 0.0% | 13.5% | 0.011 |
| Cryoprecipitate units transfused | 0±0 | 1±3 | 0.100 |
| Cryoprecipitate patients transfused (%) | 0.0% | 5.4% | 0.172 |